Pharmaceuticals Sector — activité des initiés

Suivez les achats et ventes d’initiés sur les actions de Healthcare. Découvrez quels dirigeants achètent, l’activité nette des initiés et le pourcentage du flottant échangé parmi 775 sociétés.
Les informations fournies dans ce classement sont à titre informatif uniquement et ne constituent pas un conseil financier. Nous ne recommandons aucun investissement spécifique basé sur ces critères.
Entreprises
Données
Abonnez-vous pour accéder à l'ensemble des données
Entreprise Branche d'activité Cap. boursière (USDm) # acheteurs nets Valeur nette ($) % du flottant acheté % d'actions détenues par les initiés
Pharmaceuticals Mega (1.0tn) 0 Aucune activité — 0–15%
Pharmaceuticals Mega (653.5bn) -1–5 -$10M–$100M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals Mega (443.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Mega (372.3bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals Mega (313.6bn) 0 Aucune activité — —
CH Novartis AG (NOVN)
Pharmaceuticals Mega (306.3bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Mega (255.3bn) 1–5 $10M–$100M 0–15% 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals Mega (221.8bn) -1–5 -$1M–$10M -0–15% 0–15%
DK Novo Nordisk A/S (NOVO-B)
Pharmaceuticals Mega (201.4bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (189.3bn) 0 Aucune activité — 0–15%
US Pfizer Inc (PFE)
Pharmaceuticals Large (162.7bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals Large (132.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals Large (130.4bn) 0 Aucune activité — 0–15%
FR Sanofi SA (SAN)
Pharmaceuticals Large (104.9bn) 0 Aucune activité — 0–15%
GB GSK plc (GSK)
Pharmaceuticals Large (99.8bn) 11–20 -$100K–$1M -0–15% 0–15%
AU CSL Ltd (CSL)
Pharmaceuticals Large (90.6bn) 0 Aucune activité — 0–15%
US Celgene Corp (CELG)
Pharmaceuticals Large (77.0bn) 0 Aucune activité — —
US Allergan plc (AGN)
Pharmaceuticals Large (63.7bn) 0 Aucune activité — 0–15%
DE Bayer AG (BAYN)
Pharmaceuticals Large (55.1bn) 1–5 $1M–$10M 0–15% —
Pharmaceuticals Large (51.4bn) -6–10 -$10M–$100M -0–15% 0–15%
BE Ucb SA (UCB)
Pharmaceuticals Large (49.4bn) 1–5 < $100K 0–15% 15–50%
GB Haleon PLC (HLN)
Pharmaceuticals Large (39.7bn) 1–5 < $100K 0–15% 0–15%
Pharmaceuticals Large (39.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (33.8bn) 0 Aucune activité — 0–15%
US Biogen Inc (BIIB)
Pharmaceuticals Large (33.3bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals Large (32.0bn) 0 Aucune activité — 50%+
US Zoetis Inc (ZTS)
Pharmaceuticals Large (29.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (27.6bn) -6–10 -$100M+ -0–15% 15–50%
Pharmaceuticals Large (26.7bn) -1–5 -$1M–$10M -0–15% 50%+
Pharmaceuticals Large (26.6bn) 0 Aucune activité — 0–15%
US Incyte Corp (INCY)
Pharmaceuticals Large (25.7bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals Large (21.3bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals Large (19.4bn) 0 Aucune activité — 50%+
US Viatris Inc (VTRS)
Pharmaceuticals Large (18.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (16.6bn) -6–10 -$10M–$100M -0–15% 0–15%
IN Cipla Ltd (CIPLA)
Pharmaceuticals Large (15.9bn) 0 Aucune activité — 15–50%
Pharmaceuticals Large (15.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (14.5bn) 0 Aucune activité — 0–15%
FR Ipsen SA (IPN)
Pharmaceuticals Large (14.0bn) 1–5 $100K–$1M 0–15% 50%+
Pharmaceuticals Large (13.5bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (13.2bn) 0 Aucune activité — 50%+
Pharmaceuticals Large (13.1bn) 0 Aucune activité — 0–15%
FI Orion Oyj (ORNBV)
Pharmaceuticals Large (13.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (12.9bn) 0 Aucune activité — 50%+
Pharmaceuticals Large (12.7bn) 0 Aucune activité — 15–50%
Pharmaceuticals Large (12.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Large (12.6bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Large (12.4bn) 0 Aucune activité — 50%+
US Catalent Inc (CTLT)
Pharmaceuticals Large (11.5bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (11.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals Large (11.0bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals Large (10.5bn) -6–10 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Large (10.4bn) -1–5 -$10M–$100M -0–15% 0–15%
US Mylan NV (MYL)
Pharmaceuticals Mid (8.6bn) 0 Aucune activité — 0–15%
ES Grifols SA (GRF)
Pharmaceuticals Mid (7.8bn) 0 Aucune activité — 15–50%
IN Aurobindo Pharma Ltd (AUROPHARMA)
Pharmaceuticals Mid (7.4bn) 0 Aucune activité — 50%+
Pharmaceuticals Mid (7.1bn) 0 Aucune activité — 50%+
Pharmaceuticals Mid (6.8bn) 0 Aucune activité — 50%+
Pharmaceuticals Mid (6.8bn) 0 Aucune activité — 0–15%
US Medicines Co (MDCO)
Pharmaceuticals Mid (6.8bn) 0 Aucune activité — —
Pharmaceuticals Mid (6.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals Mid (6.1bn) -1–5 -$10M–$100M -0–15% 0–15%
DK H Lundbeck A/S (HLUN-A)
Pharmaceuticals Mid (6.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals Mid (6.0bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals Mid (5.6bn) -1–5 -$1M–$10M -0–15% 50%+
Pharmaceuticals Mid (5.6bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals Mid (5.3bn) 0 Aucune activité — 0–15%
Pharmaceuticals Mid (5.2bn) 0 Aucune activité — 15–50%
Pharmaceuticals Mid (5.0bn) 0 Aucune activité — 50%+
Pharmaceuticals Mid (5.0bn) 0 Aucune activité — 50%+
Pharmaceuticals Mid (4.9bn) -1–5 -$100M+ -0–15% 0–15%
IN Ajanta Pharma Ltd (AJANTPHARM)
Pharmaceuticals Mid (4.8bn) -1–5 -$100K–$1M -0–15% 50%+
Pharmaceuticals Mid (4.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals Mid (4.6bn) 1–5 < $100K 0–15% 50%+
Pharmaceuticals Mid (4.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals Mid (4.5bn) 1–5 $100K–$1M 0–15% 15–50%
GB Indivior Ltd (INDV)
Pharmaceuticals Mid (4.3bn) 1–5 $100K–$1M 0–15% 0–15%
US Alkermes Inc (ALKS)
Pharmaceuticals Mid (4.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals Mid (4.1bn) 0 Aucune activité — 15–50%
SE Camurus AB (CAMX)
Pharmaceuticals Mid (3.8bn) -1–5 -$100K–$1M -0–15% 15–50%
US Perrigo Co (PRGO)
Pharmaceuticals Mid (3.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals Mid (3.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals Mid (3.7bn) 0 Aucune activité — 15–50%
US Organon & Co (OGN)
Pharmaceuticals Mid (3.6bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals Mid (3.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals Mid (3.5bn) 0 Aucune activité — 50%+
Pharmaceuticals Mid (3.5bn) -1–5 -$1M–$10M -0–15% 0–15%
FR Virbac SA (VIRP)
Pharmaceuticals Mid (3.2bn) 0 Aucune activité — 50%+
Pharmaceuticals Mid (3.2bn) 0 Aucune activité — 50%+
Pharmaceuticals Mid (3.2bn) 0 Aucune activité — 50%+
Pharmaceuticals Mid (2.9bn) 0 Aucune activité — 0–15%
ES Almirall SA (ALM)
Pharmaceuticals Mid (2.9bn) 0 Aucune activité — 50%+
Pharmaceuticals Mid (2.9bn) 0 Aucune activité — 15–50%
IN Laurus Labs Ltd (LAURUSLABS)
Pharmaceuticals Mid (2.8bn) 0 Aucune activité — 15–50%
Pharmaceuticals Mid (2.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals Mid (2.7bn) 0 Aucune activité — —
US Zai Lab Ltd (9688)
Pharmaceuticals Mid (2.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals Mid (2.6bn) -1–5 -< $100K -0–15% 50%+
Pharmaceuticals Mid (2.6bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals Mid (2.5bn) 0 Aucune activité — 0–15%